Science and Technology
publicado em 24/03/2010 às 22h00:00
   Dê o seu voto:

Combination chemotherapy provides anti-tumor effect in pancreatic cancer

Combination with a synthetic compound that mimics the action of a naturally occurring protein promotes cell death

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



Foto: Divulgação / UTSouthWestern
Researchers led by Rolf Brekken in mice showed that pancreatic cancer cells regress dramatically when treated with chemotherapy
  « Previous
next »  
Researchers led by Rolf Brekken in mice showed that pancreatic cancer cells regress dramatically when treated with chemotherapy

Human pancreatic cancer cells dramatically regress when treated with chemotherapy in combination with a synthetic compound that mimics the action of a naturally occurring " death-promoting" protein found in cells, researchers at

UT Southwestern Medical Center have found.

The research, conducted in mice, appears in today' s issue of Cancer Research and could lead to more effective therapies for pancreatic and possibly other cancers, the researchers said.

" This compound enhanced the efficacy of chemotherapy and improved survival in multiple animal models of pancreatic cancer," said Dr. Rolf Brekken, associate professor of surgery and pharmacology and the study' s senior author. " We now have multiple lines of evidence in animals showing that this combination is having a potent effect on pancreatic cancer, which is a devastating disease."

In this study, Dr. Brekken and his team transplanted human pancreatic tumors into mice, then allowed the tumors to grow to a significant size. They then administered a synthetic compound called JP1201 in combination with gemcitabine, a chemotherapeutic drug that is considered the standard of care for patients with pancreatic cancer. They found that the drug combination caused regression of the tumors.

" There was a 50 percent regression in tumor size during a two-week treatment of the mice," Dr. Brekken said. " We also looked at survival groups of the animals, which is often depressing in human therapeutic studies for pancreatic cancer because virtually nothing works. We found not only significant decrease in tumor size, but meaningful prolongation of life with the drug combination."

The drug combination was also effective in an aggressive model of spontaneous pancreatic cancer in mice.

The compound JP1201 was created in 2004 by UT Southwestern researchers to mimic the action of a protein called Smac. The researchers discovered Smac in 2000 and found that this protein plays a key role in the normal self-destruction process present in every cell.

Cell death, or apoptosis, is activated when a cell needs to be terminated, such as when a cell is defective or is no longer needed for normal growth and development. In cancer cells, this self-destruct mechanism is faulty and lead to breaks in the cell-death cascade of events. The synthetic Smac, or Smac mimetic, developed at UT Southwestern inhibits these breaks, allowing the cell to die.

" In essence, we' re inhibiting an inhibitor," Dr. Brekken said. " And we' re allowing the apoptotic cascade to kick off, resulting in the death of cancer cells."

UT Southwestern researchers are using Smac mimetics in breast and lung cancer research, as well. Dr. Brekken said the next step is to develop a compound based on JP1201 that can be tested in humans in clinical trials.

Source: Isaude.net
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Combination chemotherapy provides anti-tumor effect in pancreatic cancer
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Combination chemotherapy provides anti-tumor effect in pancreatic cancer


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
chemotherapy    pancreatic cancer    comprising JP1201    Rolf Brekken    University of Southern Texas   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.